InsidersTradesSigma
Track the Diamyd Medical Aktiebolag stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Market capitalisation: €158.4m. The latest transaction was disclosed on 27 July 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Diamyd Medical Aktiebolag es una empresa biofarmacéutica sueca centrada en el desarrollo de tratamientos para la diabetes tipo 1. Cotiza en la Bolsa de Estocolmo.